Comment on: Toll-like receptor-4 (TLR4) and MyD88 are required for Gastric Bypass-induced metabolic effects

Bariatric and metabolic surgery (BMS) is the most effective treatment for severe obesity, type 2 diabetes (T2D) and comorbidities. Roux-en-Y gastric bypass (RYGB) is one of the most commonly performed procedures, which has sustained effects on weight loss. The mechanisms underlying the benefits of RYGB are unclear.
Source: Surgery for Obesity and Related Diseases - Category: Surgery Authors: Source Type: research